Injection Blow Molding
vs Injection Stretch
Blow Molding: Which Process
Produces Better Bottles at Lower Cost?

IBM — INJECTION BLOW MOLDING

3-Station Simultaneous · No Preform Storage

ISBM — INJECTION STRETCH BLOW MOLDING

1-Stage or 2-Stage · Biaxial Stretch · PET Optimised

IBM — Injection-Formed Neck

ISBM — Injection-Formed + Reheat-Constrained Neck

Is the resin PET?

Yes → ISBM (2-stage for beverage commodity; 1-stage for pharmaceutical or cosmetic PET where neck precision is secondary). PET cannot be competitively processed by IBM. Stop here.
No → Continue to Q2.

Does the closure system require neck OD tolerance ≤±0.10 mm?

Yes → IBM (pharmaceutical CRC, cosmetic pump dispenser, dropper tip interference fit, spray actuator engagement). IBM achieves ±0.02–0.05 mm; ISBM 2-stage achieves ±0.10–0.20 mm. Stop here.
No → Continue to Q3.

Is the resin HDPE or PCTG?

Yes → IBM (HDPE and PCTG cannot be processed by ISBM; IBM only). Stop here.
No → Continue to Q4.

Is body wall thickness below 0.40 mm required?

Yes → ISBM (ultra-thin wall PET beverage; IBM minimum body wall approximately 0.45–0.50 mm for structural integrity at IBM blow ratios). Stop here.
No → Continue to Q5.

Is annual volume above 500 million PP or LDPE bottles per year from a single product line?

Yes → Consider 1-stage ISBM PP (1-stage ISBM PP at pharmaceutical/cosmetic scale can match IBM output at ultra-high volume; evaluate neck OD Cpk requirement per Q2 first).
No (below 500M/year per line) → IBM (IBM machine ROI, tooling flexibility and neck OD precision favour IBM below 500M per line). Continue to Q6 for confirmation.

Is the application pharmaceutical GMP primary packaging?

Yes → IBM (Cpk ≥1.33 neck OD, IQ/OQ/PQ validation, USP Class VI resin, no-parting-line PSL surface — all point to IBM for pharmaceutical primary packaging regardless of volume below 500M/year per line). View the EP-ZQ series for machine selection.
No → IBM or 1-stage ISBM are both viable for non-pharmaceutical applications at this stage — make the final selection based on total cost of ownership analysis including tooling, resin, energy and closure system compatibility cost.

Can IBM process PET to produce PET pharmaceutical bottles?

IBM can technically process PET (PET is melt-injectable), but cannot produce competitive pharmaceutical PET bottles because: (1) IBM without axial stretch cannot induce PET biaxial orientation — unoriented PET IBM bottles are cloudy (haze 20–50%), brittle, and have poor barrier compared to ISBM-oriented PET; (2) IBM blow-only PET at 260–280°C barrel generates acetaldehyde at levels above FDA/EFSA food contact limits unless very carefully managed — pharmaceutical regulatory risk; (3) PET crystallises rapidly at IBM blow station temperatures, causing mould fouling and surface whitening on the blown bottle. In practice, pharmaceutical buyers do not specify IBM for PET bottles. Pharmaceutical PET pharmaceutical packaging — where it exists, e.g. oral liquid PET bottle — uses 1-stage ISBM PP. The dominant pharmaceutical IBM resins are PP and HDPE. Korea Ever-Power does not offer EP-ZQ machines for PET IBM and does not recommend PET for IBM applications.

Is 1-stage ISBM a viable alternative to IBM for pharmaceutical PP bottles at high volume?

1-stage ISBM PP is a viable alternative to IBM PP for pharmaceutical applications where neck OD tolerance of ±0.10 mm or better is achievable. 1-stage ISBM (also called integrated IBM in some literature) retains the preform on a mandrel through to the blow stage without a separate reheat cycle — so it avoids the neck distortion risk of 2-stage ISBM reheat. 1-stage ISBM PP neck OD: ±0.05–0.10 mm — better than 2-stage ISBM, comparable to IBM at the low end. For pharmaceutical oral solid tablet containers where CRC torque consistency requires ±0.05 mm: IBM is preferred (confirmed ±0.02–0.05 mm). For pharmaceutical oral liquid bottles where screw cap torque variation of ±0.10 mm is acceptable: 1-stage ISBM PP is a viable alternative. For cosmetic where PCTG is required: 1-stage ISBM is not viable (PCTG does not stretch-orient). The correct choice between IBM and 1-stage ISBM PP ultimately depends on closure system tolerance, resin specification and annual volume — not on a blanket process preference.

Why can’t ISBM process HDPE? It is commonly blow-moulded by EBM.

HDPE cannot be biaxially stretch-blow-moulded (ISBM) because HDPE crystallises rapidly as it cools below approximately 130°C — which occurs faster than the biaxial stretch-blow cycle can be completed at any practical production rate. HDPE’s crystallisation is so rapid that by the time the preform has cooled from injection and been placed in the blow mould, the HDPE body zone has already exceeded the maximum stretch temperature and lost its ductility for biaxial orientation. HDPE can be blow-moulded by EBM (extrusion blow moulding) where the parison is blown immediately from the extruder at full melt temperature with no cooling interval — but EBM produces HDPE bottles with the characteristic body parting line and ±0.15–0.25 mm neck OD variation that disqualifies EBM HDPE from pharmaceutical precision closure applications. IBM is the only blow-moulding process that can produce HDPE pharmaceutical bottles with ±0.05 mm neck OD and no body parting line — because IBM forms the preform and blows it at melt temperature without any cooling or reheat interval, matching HDPE’s processing requirements exactly. This is why HDPE IBM is the preferred process for pharmaceutical HDPE primary containers where precision closure engagement is required.

What is the maximum body OD achievable by IBM relative to the neck OD?

IBM body OD is constrained by the mandrel withdrawal geometry: the finished bottle must be stripped from the mandrel (core rod) at Station 3, which requires the body minimum internal diameter to be equal to or larger than the mandrel OD at any point along the bottle body. In practice, the useful body OD maximum is approximately 2.5–3.0× the neck OD for standard IBM bottle geometries. For a 28 mm neck: maximum body OD approximately 70–84 mm. For a 38 mm neck (wide-mouth sports bottle): maximum body OD approximately 95–114 mm. Bodies wider than 3.0× neck OD require either a collapsible mandrel design (expensive, complex) or a reduction to shoulder taper to allow mandrel extraction — both are viable but add tooling cost. Korea Ever-Power Ansan-si designs IBM bottle mandrel geometry to the specific bottle 3D model: send bottle CAD for IBM feasibility review. ISBM has no equivalent body OD constraint relative to neck OD — the stretch rod is withdrawn before the bottle is ejected, and the blow mould can accommodate arbitrary body OD. This is why large-body-OD / narrow-neck-OD bottles (wine bottles, large wide-body water bottles) are ISBM rather than IBM.

What is the IBM minimum and maximum bottle volume range?

IBM bottle volume range on Korea Ever-Power EP-ZQ series: minimum approximately 1 ml (ophthalmic dropper, ZQ40, LDPE, very small mandrel — specialist application); practical minimum for commercial pharmaceutical: 5 ml (ophthalmic dropper, ZQ40/ZQ60, LDPE or PCTG, 20–24 cavities). Standard pharmaceutical minimum: 10 ml (eye serum dropper, ZQ40, 9 cavities, or ZQ135 30 cavities PCTG). Standard maximum: 2,000 ml on ZQ60; 5,000 ml on ZQ135 (large daily chemical or food supplement container — very low blow ratio at large volume, mandrel withdrawal is the constraint). Practical daily chemical maximum: 1,000 ml (ZQ80, 2 cavities). Above 1,000 ml: IBM tooling and cycle cost per litre becomes unfavourable versus EBM; EBM is preferred for HDPE jerricans and large PP daily chemical above 1,000 ml. ISBM (PET 2-stage) minimum approximately 50 ml; maximum approximately 20,000 ml (large PET water jugs). IBM and ISBM overlap most closely in the 30–500 ml pharmaceutical and cosmetic segment — which is where the IBM vs ISBM process selection decision is most actively made.

Can a single IBM machine produce multiple different bottle formats?

Yes, with mould changeover. Korea Ever-Power EP-ZQ series IBM machines are designed for mould changeover between formats using the same machine: different injection cavity + core rod + blow mould sets are installed for each bottle format. Changeover time: approximately 4–8 hours for a full mould set change on EP-ZQ80 or ZQ110 at Ansan-si (includes mould installation, temperature stabilisation, and first-off QC check). Multiple format moulds for the same machine can be purchased progressively — a pharmaceutical buyer starting with 100 ml tablet bottles can add 60 ml and 250 ml format moulds later without changing the machine. Mould interchangeability constraint: all format moulds for a given ZQ model must be within the ZQ model’s injection weight, platen dimensions and blow station stroke envelope. Korea Ever-Power confirms format compatibility at tooling quotation stage.

For a Korean pharmaceutical company currently using PET ISBM bottles for oral liquid products, is switching to PP IBM beneficial?

This is one of the most common evaluation scenarios in Korean pharmaceutical packaging. The answer depends on three factors specific to the product and facility: (1) Neck OD tolerance requirement: if the oral liquid product uses a pump dispenser or CRC requiring ±0.05 mm neck OD, PET 2-stage ISBM at ±0.15 mm is likely causing capping line inconsistency — switch to IBM PP is technically beneficial. If the product uses a standard screw cap with wide engagement band (acceptable at ±0.15 mm), PET ISBM neck precision is adequate and switching has no neck-dimension benefit. (2) Regulatory compliance: Korean MFDS oral liquid containers in PET require EU 10/2011 or FDA 21 CFR 177.1480 PET compliance documentation. PP IBM requires FDA 21 CFR 177.1520 and Ph.Eur. 3.1.3 — both are well-established and straightforward to document with Korea Ever-Power’s documentation package. Neither resin has a regulatory compliance advantage in Korea. (3) Chemical compatibility: some oral liquid pharmaceutical formulations — particularly those with high-concentration alcohol, complex flavouring agents or ethanol-based vehicles — have better compatibility in PP than PET (PET can absorb certain flavour compounds from liquid formulations, shifting taste profile over shelf life; PP has lower sorption). For alcohol-based oral liquid, PP IBM may provide a shelf-life quality advantage over PET ISBM. Korea Ever-Power recommends a 6-week accelerated stability study (40°C, 75% RH) in PP IBM bottle vs current PET container before committing to the switch.

Where can I find IBM machine specifications and detailed application guides for pharmaceutical, cosmetic and daily chemical IBM?

The Korea Ever-Power EP-ZQ injection blow molding machine series page provides full technical specifications for each EP-ZQ model (ZQ40 through ZQ135), including confirmed cavity counts at each bottle volume format, machine dimensions, power requirements and material compatibility. The IBM machine replacement guide compares Korea Ever-Power EP-ZQ against Jomar IBM, SUMA iB, Uniloy UIB and Bloma IBM across all tonnage classes — useful for buyers currently operating American-style IBM machines evaluating European IBM alternatives. For IBM machine selection support specific to your bottle volume, resin and annual production requirement, contact Korea Ever-Power Ansan-si for a 48-hour feasibility assessment.